DE3587741D1 - Behandlung von Hautkrankheiten. - Google Patents

Behandlung von Hautkrankheiten.

Info

Publication number
DE3587741D1
DE3587741D1 DE85305552T DE3587741T DE3587741D1 DE 3587741 D1 DE3587741 D1 DE 3587741D1 DE 85305552 T DE85305552 T DE 85305552T DE 3587741 T DE3587741 T DE 3587741T DE 3587741 D1 DE3587741 D1 DE 3587741D1
Authority
DE
Germany
Prior art keywords
treatment
skin diseases
diseases
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE85305552T
Other languages
English (en)
Other versions
DE3587741T2 (de
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of DE3587741D1 publication Critical patent/DE3587741D1/de
Publication of DE3587741T2 publication Critical patent/DE3587741T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE3587741T 1984-08-15 1985-08-05 Behandlung von Hautkrankheiten. Expired - Fee Related DE3587741T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848420771A GB8420771D0 (en) 1984-08-15 1984-08-15 Treatment of skin disorders

Publications (2)

Publication Number Publication Date
DE3587741D1 true DE3587741D1 (de) 1994-03-17
DE3587741T2 DE3587741T2 (de) 1994-06-23

Family

ID=10565392

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3587741T Expired - Fee Related DE3587741T2 (de) 1984-08-15 1985-08-05 Behandlung von Hautkrankheiten.

Country Status (10)

Country Link
EP (1) EP0173478B1 (de)
JP (1) JPS6156136A (de)
AU (1) AU573372B2 (de)
CA (1) CA1264670A (de)
DE (1) DE3587741T2 (de)
GB (1) GB8420771D0 (de)
HK (1) HK107594A (de)
IE (1) IE62292B1 (de)
SG (1) SG96694G (de)
ZA (1) ZA855916B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2593449B2 (ja) * 1986-06-14 1997-03-26 キヤノン電子株式会社 ディスク駆動装置
JP2572378B2 (ja) * 1986-07-18 1997-01-16 キヤノン電子株式会社 ステツピングモ−タの駆動制御方式
DE3805064A1 (de) * 1988-02-18 1989-10-05 Hoechst Ag Pharmazeutische zubereitungen zur geburtseinleitung, fuer den schwangerschaftsabbruch und zur verwendung als kontrazeptivum
HU205860B (en) * 1990-08-24 1992-07-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositiojns for topical treating psoriasis
JPH07114761B2 (ja) * 1991-08-29 1995-12-13 ジェクス株式会社 皮膚清拭用品
ATE227122T1 (de) * 1993-09-03 2002-11-15 Smithkline Beecham Corp Stabilisierte tablettenformulierung
US5707981A (en) * 1994-07-28 1998-01-13 Psorial, L.L.C. Synergistic pharmaceutical compositions
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
DK0823897T3 (da) * 1995-05-01 2004-12-06 Scarista Ltd Nicotinsyreestere og farmaceutiske præparater indeholdende disse
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
US5690947A (en) * 1996-08-30 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Borage seed oil as an anti-irritant in compositions containing hydroxy acids or retinoids
US5855893A (en) * 1997-02-14 1999-01-05 Elizabeth Arden Co., Division Of Conopco, Inc. Trichodesma lanicum seed extract as an anti-irritant in compositions containing hydroxy acids or retinoids
GB9724802D0 (en) * 1997-11-24 1998-01-21 Unilever Plc Antiperspirant or deodorant compoistions
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
FR2860434B1 (fr) * 2003-10-06 2006-10-27 Dermo Cosmetique Animale L D C Composition dermo-cosmetique pour animaux de compagnie.
GB0413730D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
JP5002462B2 (ja) * 2004-12-09 2012-08-15 バイエル・アニマル・ヘルス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 酸によるグルココルチコイドエステルの安定化
US20080161275A1 (en) * 2006-12-05 2008-07-03 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of inflammatory disease
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
WO2012153832A1 (ja) 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CA2905587A1 (en) 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
US11330817B2 (en) 2013-12-04 2022-05-17 Nippon Suisan Kaisha, Ltd. Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
SG10201912145VA (en) 2014-06-04 2020-02-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
CN114931570A (zh) * 2022-05-30 2022-08-23 广东省农业科学院动物卫生研究所 一种具有治疗动物脂溢性皮炎功能的产品及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082624A (en) * 1965-02-26 1967-09-06 Calmic Ltd Improvements in or relating to therapeutically active compounds
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4305936A (en) * 1980-10-09 1981-12-15 Dermik Laboratories Topical corticosteroid formulations
US4346086A (en) * 1981-06-09 1982-08-24 Beiersdorf Aktiengesellschaft Corticosteroid-containing cream
US4343798A (en) * 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels

Also Published As

Publication number Publication date
AU573372B2 (en) 1988-06-02
CA1264670A (en) 1990-01-23
IE62292B1 (en) 1995-01-25
AU4586485A (en) 1986-02-20
HK107594A (en) 1994-10-14
IE851941L (en) 1986-02-15
JPS6156136A (ja) 1986-03-20
EP0173478A1 (de) 1986-03-05
GB8420771D0 (en) 1984-09-19
DE3587741T2 (de) 1994-06-23
ZA855916B (en) 1986-04-30
EP0173478B1 (de) 1994-02-02
SG96694G (en) 1994-10-28

Similar Documents

Publication Publication Date Title
DE3587741D1 (de) Behandlung von Hautkrankheiten.
DE3585981D1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.
DE3855489D1 (de) Behandlung von Hautfalten
ATE131068T1 (de) Behandlung von pathologischen zuständen und krankheiten.
DE3675356D1 (de) Behandlung von kupferblaettern.
OA08581A (en) Treatment of diseases caused by retroviruses.
DE68909219D1 (de) Behandlung von obesitas.
DE3582894D1 (de) Hautbehandlungsmittel.
DE69019488D1 (de) Behandlung von Geflügel.
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3780091D1 (de) Behandlung von pilzinfektionen.
DE3576328D1 (de) Behandlung feuerfester gegenstaende.
DE68907423D1 (de) Behandlung der akne.
DE69018043D1 (de) Behandlung von Geflügel.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
DE3777861D1 (de) Behandlung von gasen.
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE3680881D1 (de) Behandlung von hologrammen.
DE3670956D1 (de) Behandlung von fluessigkeiten.
DE3883966D1 (de) Behandlung durchlässiger membranen.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE3777779D1 (de) Behandlung des haares.
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee